Rising demand and more frequent claims push up costs, directly impacting premiums.
US Department of Commerce launched a “Section 232” on medical products.
They are tiny, concentrated balls of flavours and vitamins which dissolve in liquid.
It said sales applications had lifted 23% between July and August.